Sponsored Links
BRIEF-Santarus up in premarket after FDA ok's ulcerative colitis dug
NEW YORK |
NEW YORK Jan 15 (Reuters) - Santarus Inc : * Up 8.6 percent premarket after FDA OK's its oral drug to treat a type of inflammatory bowel disease
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters